There are number of challenges in the development of a HIV vaccine. Dr Zoe Moodie (Fred Hutchinson Cancer Center, Seattle, WA, USA) joins touchINFECTIOUS DISEASES to discuss the challenges and the current status in the development of HIV vaccines.
The presentation entitled ‘Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T cell correlates of HIV-1 acquisition risk’ was presented at the International AIDS Society (IAS) 29 July – 2 August, 2022.
Questions:
- What are the challenges of developing a vaccine against HIV? (00:25)
- What is the current status of HIV vaccine development? (01:08)
Disclosures: Zoe Moodie has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
